Asklepios Academic City Hospital, Bad Wildungen – Germany
About Prof. MD Christian Wulfing
Prof. Dr. med. Christian Wülfing is a globally renowned Urologist with over 27 years of clinical experience, specialising in urology, special urological surgery, and drug tumour therapy. University of Münster-trained, he serves as Chief of the Department of Urology at Asklepios Klinik Altona, Hamburg, and is widely recognised for his expertise in uro-oncology and minimally invasive urological surgery.
- 27+ years of experience in urology and uro-oncology
- University of Münster Medical Faculty — Habilitation 2005, Extraordinary Professorship 2009
- 272+ peer-reviewed scientific publications
- Multiple-time FOCUS Top Physician List — Uro-Oncology, Germany
- Press Spokesperson — German Society of Urology (DGU)
Qualifications & Credentials
Medical Degrees
- Graduation (Medical Degree) — University of Münster, Germany
- Doctorate (Dr. med.), 1999 — University of Münster, Germany — "Immunohistochemical Studies of Metallothionein and the p53 Tumor Suppressor Gene in Bladder Carcinoma"
Fellowships & Special Training
- Habilitation in Urology, 2005 — University of Münster — "Molecular Prognostic Markers of Invasive Bladder Cancer and Their Importance for Molecular Therapy"
- Extraordinary Professorship — Westfälische Wilhelms-Universität Münster, 2009
- Additional Qualifications in Drug Tumour Therapy, 2006
- Specialised training in Special Urological Surgery
- Specialised training in Robotic Urology (da Vinci Xi)
Certifications & Accreditations
- German Medical Council (Ärztekammer) Registration
- Member & Press Spokesperson — German Society of Urology (DGU)
- Vice-Chairman — PatientenAkademie der Deutschen Urologen
- Board Member — Working Group on Urological Oncology (AUO), German Cancer Society
- Member — American Society of Clinical Oncology (ASCO)
- Member — European Association of Urology (EAU)
Areas of Expertise
Major Conditions Treated
- Prostate Cancer (Localized and Metastatic)
- Bladder Cancer (including Invasive Bladder Cancer)
- Kidney Cancer / Renal Cell Carcinoma
- Testicular Cancer
- Benign Prostatic Hyperplasia (BPH)
- Kidney and Ureteral Stones
- Urinary Incontinence
- Bladder Function Disorders
- Sexual Dysfunction (Erectile Dysfunction)
- Adrenal Tumours
- Urological Trauma
Sub-specialties
- Uro-Oncology: Internationally recognised specialist in kidney, bladder, and prostate cancer — making him a top urologist with international expertise.
- Robotic & Minimally Invasive Urology: Da Vinci Xi robotic platform for radical prostatectomy and other procedures.
- Drug Tumour Therapy: Specialist in modern targeted therapies and chemotherapy.
- Organ-Preserving Surgery: Retroperitoneoscopic kidney tumour surgery and laparoscopic urology.
Advanced Procedures & Treatments
- Robotic-Assisted Radical Prostatectomy (da Vinci Xi)
- Laparoscopic and Open Radical Cystectomy with Modern Urinary Diversion
- Endoscopic Removal of Bladder Tumours
- Retroperitoneoscopic Organ-Preserving Kidney Tumour Surgery
- Greenlight Laser Vaporisation (PVP) for BPH
- Thulium Laser Vapoenucleation (ThuVEP)
- Aquablation for Large Prostate Volumes
- Anatomical Endoscopic Enucleation of the Prostate
- Minimally Invasive Kidney Stone Removal (Mini-Endoscopes & Laser)
- Drug Tumour Therapy (Chemotherapy and Targeted Therapy)
- Outpatient Uro-Oncology Day Clinic
List of Disease and Treatment for which Prof. MD Christian Wulfing can be consulted
Professional Experience
Current Affiliation
- Asklepios Klinik Altona, Paul-Ehrlich-Straße 1, Hamburg, Germany — Chief of Department of Urology / Chefarzt (April 2010 – Present). (Note: Per your input, Bad Wildungen is listed as the city; the publicly indexed primary practice site of Prof. Wülfing is Asklepios Klinik Altona, Hamburg, Germany. Cancer Rounds confirms the precise practice location at the time of booking.)
Past Affiliations
- Asklepios Westklinikum Hamburg, Germany — Head Physician of Department of Urology, 2017–2020
- University Hospital Münster (Westfälische Wilhelms-Universität), Germany — Faculty in Urology and Tumour Medicine
Academic & Research Roles
- Extraordinary Professor — Westfälische Wilhelms-Universität Münster (since 2009)
- Press Spokesperson — German Society of Urology (DGU) since 2015
- Vice-Chairman — PatientenAkademie der Deutschen Urologen
- Board Member — Working Group on Urological Oncology (AUO), German Cancer Society
- Member — Medical Board of the Urological Foundation for Health
- Co-developer of "Entscheidungshilfe Prostatakrebs" — German national online decision aid for prostate cancer (used by 11,000+ users)
- 2000–2009 — Regular teaching activities in main urological lectures and tumour medicine model course (PoLiT) at University Hospital Münster
Key Achievements
- 27+ years of urological practice
- 272+ peer-reviewed scientific publications
- Multiple-time FOCUS Top Physician List — Uro-Oncology
- Co-developer of national prostate cancer decision aid
- UserScore 91% across multiple peer-review platforms
Awards & Recognitions
National & International Awards
- FOCUS Top Physician List (Top-Mediziner Deutschlands) — Uro-Oncology, multiple years
- Poster Prize — German Society of Urology (DGU), 2003
- "Teacher of the Year" Award — Westfälische Wilhelms-Universität, Münster, 2003
- Best Recruitment and Documentation Center Award — Working Group on Urological Oncology, 2003
- Merit Award — American Society for Clinical Oncology (ASCO), 2004
- Paul Mellin Prize — North Rhine-Westphalian Society for Urology, 2004 and 2007
Professional Memberships
- German Society of Urology (DGU) — Press Spokesperson and Board Member
- Working Group on Urological Oncology (AUO), German Cancer Society — Board Member
- European Association of Urology (EAU)
- American Association of Clinical Oncology (ASCO)
- American Urological Association (AUA)
- PatientenAkademie der Deutschen Urologen — Vice-Chairman
Research & Publications
Published Papers (Selected)
- Wülfing C, et al. "Cyclooxygenase-2 (Cox-2) and Her-2/neu Expression in Bladder Cancer: Correlation to Clinicopathological Data and Long-Term Follow-Up." European Urology, 2003.
- Wülfing C, et al. "Endothelin-1, ET-A and ET-B-Receptor Expression in Bladder Cancer." Annual Award Meeting of the C.E. Alken Prize Winners, 2002.
- Huber J, Karschuck P, Valdix J, ... Wülfing C, Groeben C. "Online Decision Aid for Patients with Prostate Cancer Evaluated by 11,290 Patients and 91 Urologists in Germany." BJU International, 2024;134:239–248.
- Miller K, Steiner U, Machtens S, ... Wülfing C. "Phase II Study of Combination Chemotherapy with Weekly Docetaxel and Intermittent Estramustine in Patients with HRPC." Annual Meeting, ASCO 2002.
- 272+ additional peer-reviewed publications on bladder cancer molecular markers, prostate cancer therapy, renal surgery, and uro-oncology.
Ongoing Research & Clinical Interests
- Molecular prognostic markers of invasive bladder cancer
- Targeted therapy in urological cancers
- Robotic and minimally invasive urology
- Patient decision-aid tools in prostate cancer
Estimated Treatment Costs
| Procedure / Consultation | Estimated Cost (EUR) | Estimated Cost (USD) |
|---|---|---|
| Urology Consultation (Private) | €150 – €350 | $160 – $380 |
| Robotic-Assisted Radical Prostatectomy | €15,000 – €25,000 | $16,000 – $27,000 |
| Radical Cystectomy with Urinary Diversion | €20,000 – €35,000 | $21,000 – $38,000 |
| Laparoscopic Partial Nephrectomy | €12,000 – €20,000 | $13,000 – $22,000 |
| Greenlight Laser / ThuVEP for BPH | €5,000 – €10,000 | $5,400 – $11,000 |
| Endoscopic Bladder Tumour Resection | €3,500 – €7,500 | $3,800 – $8,000 |
*Indicative estimates only for treatment in Germany. Actual costs subject to hospital pricing, case complexity, and insurance. Contact Cancer Rounds for a personalised quote and international medical-tourism coordination.
Frequently Asked Questions
1. What advanced technologies does Prof. MD Christian Wulfing use in Urologist treatment?
Prof. MD Christian Wülfing uses the da Vinci Xi robotic surgical platform, advanced Greenlight and Thulium laser systems for BPH, retroperitoneoscopic organ-preserving kidney tumour surgery, contemporary mini-endoscopes for stone disease, and modern targeted therapy and chemotherapy protocols.
2. What conditions does Prof. MD Christian Wulfing specialize in treating?
Prof. MD Christian Wülfing specialises in prostate cancer, bladder cancer, kidney cancer, testicular cancer, BPH, kidney stones, and complex uro-oncology — making him an internationally recognised urologist specialist in Germany and one of the top urology doctors for uro-oncology and robotic urology in Europe.
3. How do I book an appointment with Prof. MD Christian Wulfing?
Appointments with Prof. MD Christian Wülfing can be booked directly through the Cancer Rounds website or by contacting their international patient department for priority scheduling, including coordination with German hospital staff.
4. Can international patients receive treatment from Prof. MD Christian Wulfing?
Yes. Cancer Rounds provides full assistance for international patients seeking treatment from Prof. MD Christian Wülfing in Germany, including medical visa invitation letters, airport transfers, German-English interpretation, and local accommodation coordination.
5. What support is available for international patients?
International patients benefit from a dedicated concierge service provided by Cancer Rounds, including German-English language interpretation, financial counselling for treatment in Germany, and pre-travel virtual consultations to review medical records before arrival.
6. Does Prof. MD Christian Wulfing offer second opinions for Urologist cases?
Yes. Second opinion consultations with Prof. MD Christian Wülfing can be arranged via Cancer Rounds for international patients seeking expert review of prostate cancer, bladder cancer, kidney cancer, BPH, or complex uro-oncology cases from a senior internationally-renowned Urologist in Germany.
